Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen

被引:641
|
作者
Di Lullo, GA
Sweeney, SM
Körkkö, J
Ala-Kokko, L
San Antonio, JD
机构
[1] Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
[4] Tulane Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70112 USA
[5] Tulane Univ, Hlth Sci Ctr, Ctr Gene Therapy, New Orleans, LA 70112 USA
[6] Univ Oulu, Dept Med Biochem, SF-90220 Oulu, Finland
[7] Univ Oulu, Bioctr, Collagen Res Unit, SF-90220 Oulu, Finland
关键词
D O I
10.1074/jbc.M110709200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type I collagen is the most abundant protein in humans, and it helps to maintain the integrity of many tissues via its interactions with cell surfaces, other extracellular matrix molecules, and growth and differentiation factors. Nearly 50 molecules have been found to interact with type I collagen, and for about half of them, binding sites on this collagen have been elucidated. In addition, over 300 mutations in type I collagen associated with human connective tissue disorders have been described. However, the spatial relationships between the known ligand-binding sites and mutation positions have not been examined. To this end, here we have created a map of type I collagen that includes all of its ligand-binding sites and mutations. The map reveals the existence of several hot spots for ligand interactions on type I collagen and that most of the binding sites locate to its C-terminal half. Moreover, on the collagen fibril some potentially relevant relationships between binding sites were observed including the following: fibronectin- and certain integrin-binding regions are near neighbors, which may mechanistically relate to fibronectin-dependent cell-collagen attachment; proteoglycan binding may potentially impact upon collagen fibrillogenesis, cell-collagen attachment, and collagen glycation seen in diabetes and aging; and mutations associated with osteogenesis imperfecta and other disorders show apparently nonrandom distribution patterns within both the monomer and fibril, implying that mutation positions correlate with disease phenotype. These and other observations presented here may provide novel insights into evaluating type I collagen functions and the relationships between its binding partners and mutations.
引用
收藏
页码:4223 / 4231
页数:9
相关论文
共 50 条
  • [1] Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human-type I collagen
    San Antonio, JD
    Di Lullo, GA
    Sweeney, SM
    Körkkö, J
    Ala-Kokko, L
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 9A - 9A
  • [2] MAPPING THE LIGAND-BINDING SITES OF G-PROTEIN COUPLED RECEPTORS
    STRADER, CD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 262 - MEDI
  • [3] RNA protein interactions governing expression of the most abundant protein in human body, type I collagen
    Stefanovic, Branko
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2013, 4 (05) : 535 - 545
  • [4] Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I
    Beher, D
    Hesse, L
    Masters, CL
    Multhaup, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (03) : 1613 - 1620
  • [5] MAPPING TRANSITION-STATES OF PROTEIN UNFOLDING BY PROTEIN ENGINEERING OF LIGAND-BINDING SITES
    SANCHO, J
    MEIERING, EM
    FERSHT, AR
    JOURNAL OF MOLECULAR BIOLOGY, 1991, 221 (03) : 1007 - 1014
  • [6] FUNCTIONAL MAPPING OF THE LIGAND-BINDING SITES OF G-PROTEIN COUPLED RECEPTORS
    FONG, TM
    STRADER, CD
    MEDICINAL RESEARCH REVIEWS, 1994, 14 (04) : 387 - 399
  • [7] CHARACTERIZATION OF A DOMAIN OF A HUMAN TYPE-I INTERFERON RECEPTOR PROTEIN INVOLVED IN LIGAND-BINDING
    EID, P
    TOVEY, MG
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1995, 15 (03): : 205 - 211
  • [8] Novel Mutations Within Collagen Alpha1(I) and Alpha2(I) Ligand-Binding Sites, Broadening the Spectrum of Osteogenesis Imperfecta - Current Insights Into Collagen Type I Lethal Regions
    Salacinska, Kinga
    Pinkier, Iwona
    Rutkowska, Lena
    Chlebna-Sokol, Danuta
    Jakubowska-Pietkiewicz, Elzbieta
    Michalus, Izabela
    Kepczynski, Lukasz
    Salachna, Dominik
    Jamsheer, Aleksander
    Bukowska-Olech, Ewelina
    Jaszczuk, Ilona
    Jakubowski, Lucjusz
    Gach, Agnieszka
    FRONTIERS IN GENETICS, 2021, 12
  • [9] Mapping of a ligand-binding site for the human thromboxane A2 receptor protein
    Turek, JW
    Halmos, T
    Sullivan, NL
    Antonakis, K
    Le Breton, GC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (19) : 16791 - 16797
  • [10] Structural and Molecular Biology of Type I Galactosemia: Disease-associated Mutations
    McCorvie, Thomas J.
    Timson, David J.
    IUBMB LIFE, 2011, 63 (11) : 949 - 954